SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029706
Filing Date
2023-08-21
Accepted
2023-08-21 17:16:04
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 995222
2 ex31-1.htm EX-31.1 11065
3 ex32-1.htm EX-32.1 4588
  Complete submission text file 0001493152-23-029706.txt   5161568

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE endv-20230630.xsd EX-101.SCH 41620
5 XBRL CALCULATION FILE endv-20230630_cal.xml EX-101.CAL 42087
6 XBRL DEFINITION FILE endv-20230630_def.xml EX-101.DEF 211426
7 XBRL LABEL FILE endv-20230630_lab.xml EX-101.LAB 356600
8 XBRL PRESENTATION FILE endv-20230630_pre.xml EX-101.PRE 280114
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 724891
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 231190012
SIC: 3845 Electromedical & Electrotherapeutic Apparatus